James O. Armitage, and Dan L. LongoFrom the University of Nebraska School of Medicine, Omaha (J.O.A.).
{"title":"霍奇金淋巴瘤的治疗--还能更好吗?","authors":"James O. Armitage, and Dan L. LongoFrom the University of Nebraska School of Medicine, Omaha (J.O.A.).","doi":"10.1056/nejme2408724","DOIUrl":null,"url":null,"abstract":"The approach to Hodgkin’s lymphoma treatment has emphasized the use of chemotherapy agents and radiation therapy to kill cancer cells. In the past, radiation therapy was able to cure some patients ...","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":96.2000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Therapy for Hodgkin’s Lymphoma — Can It Get Any Better?\",\"authors\":\"James O. Armitage, and Dan L. LongoFrom the University of Nebraska School of Medicine, Omaha (J.O.A.).\",\"doi\":\"10.1056/nejme2408724\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The approach to Hodgkin’s lymphoma treatment has emphasized the use of chemotherapy agents and radiation therapy to kill cancer cells. In the past, radiation therapy was able to cure some patients ...\",\"PeriodicalId\":54725,\"journal\":{\"name\":\"New England Journal of Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":96.2000,\"publicationDate\":\"2024-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"New England Journal of Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1056/nejme2408724\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"New England Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1056/nejme2408724","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Therapy for Hodgkin’s Lymphoma — Can It Get Any Better?
The approach to Hodgkin’s lymphoma treatment has emphasized the use of chemotherapy agents and radiation therapy to kill cancer cells. In the past, radiation therapy was able to cure some patients ...
期刊介绍:
The New England Journal of Medicine (NEJM) stands as the foremost medical journal and website worldwide. With an impressive history spanning over two centuries, NEJM boasts a consistent publication of superb, peer-reviewed research and engaging clinical content. Our primary objective revolves around delivering high-caliber information and findings at the juncture of biomedical science and clinical practice. We strive to present this knowledge in formats that are not only comprehensible but also hold practical value, effectively influencing healthcare practices and ultimately enhancing patient outcomes.